Navamedic ASA ( (DE:N1A) ) has provided an announcement.
Navamedic ASA has reached an agreement to reduce the outstanding loans to Observe Medical ASA by 50%, contingent on certain conditions, including a new equity injection and similar debt reductions by other creditors. This agreement could lead to milestone payments for Navamedic based on sales achievements, potentially impacting its financial position and market strategy.
More about Navamedic ASA
Navamedic ASA is a Nordic pharmaceutical company focused on providing high-quality prescription, consumer health, and hospital products to hospitals and pharmacies. The company addresses public health concerns such as obesity, Parkinson’s disease, antibiotics, and metabolism, and operates in the Nordics and Benelux regions. Navamedic has been listed on the Oslo Stock Exchange since 2006 and is headquartered in Oslo, Norway.
YTD Price Performance: -28.54%
Technical Sentiment Signal: Strong Buy
Current Market Cap: €27.06M
For an in-depth examination of N1A stock, go to TipRanks’ Stock Analysis page.